Results 71 - 80 of 208 : Previous 4 5 6 7 8 9 10 11 12 Next
Corcept's Devotion to Its Lead Drug
It will try again with its compound for psychotic depression.
No Blood-Pumping Love for Merck and Schering
Merck and Schering don't heart the ACC.
Allergic Reaction to Singulair News?
The FDA warns the public about potential side effects of Merck's allergy treatment.
The heart docs are presenting all weekend long.
The FDA puts a clinical hold on Dynavax's lead program.
Who's fallen hardest? Who can bounce highest?
WuXi signs more drug development deals and buys a U.S. manufacturing services company.
Pfizer's Celebrex Aches and Pains
An appeals court tells the company to be grateful for what it's got.
Alnylam presents proof of concept, but where's the proof that it cures a disease?
Merck's Complicated Partnerships
It's enough to make your head spin.
Legal Information © 1995 - 2008 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK